Author: A. Ant, CADC-II, Licensing & Accreditation Expert
Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.
Apply now: BHA License Application Packet | Questions: (360) 236-4700
Outpatient SUD treatment in Washington runs through the same Behavioral Health Agency (BHA) license structure as residential care, under the Washington State Department of Health (DOH), just with an outpatient certification instead of a residential one (a residential program also needs a separate residential treatment facility license, which an outpatient office doesn’t). That shared structure is a real advantage: you’re building one relationship with one agency, not juggling separate licensing bodies depending on level of care.
The Outpatient Certification
Outpatient SUD treatment falls under a BHA license with the behavioral health outpatient intervention, assessment and treatment certification added under WAC 246-341. DOH reviews your specific program design, staffing, clinical protocols, and physical space, against outpatient-level standards, distinct from what residential or withdrawal management certifications require.
Correction (October 2026): An earlier version of this guide called the outpatient service an “endorsement,” where WAC 246-341-0300 uses the word certification, and gave the wrong mailing address for applications sent with a fee. Both now match WAC 246-341-0300 and DOH’s June 2026 application packet.
An initial on-site DOH review is still required before the certification is granted, even for a standard outpatient office. Don’t assume the lighter physical-plant footprint of an outpatient program means a lighter review.
Deemed Status Applies to Outpatient Programs Too
Washington’s deemed-status system under WAC 246-341-0310 isn’t limited to higher-acuity levels of care. If your agency is accredited by CARF, The Joint Commission, or the Council on Accreditation for the outpatient services you provide, DOH will hand ongoing inspection responsibility for that service to your accreditor, replacing its own regular inspection schedule entirely. You still need DOH’s initial on-site review first, and deeming doesn’t waive any state or federal statutory requirement, but the ongoing burden reduction is real and applies just as much to a standard outpatient program as it does to residential care.
Medication-Assisted Treatment in Outpatient Settings
An outpatient program doesn’t need to become a full opioid treatment program to support medication-assisted treatment. Many Washington outpatient providers offer buprenorphine alongside counseling through a prescriber on staff or a documented referral relationship. That prescriber no longer needs a special federal waiver, which the Consolidated Appropriations Act, 2023 eliminated, only a standard DEA registration. Our advice is to have your policies name the actual access pathway, not just a general statement that referrals happen “as needed.”
Running a Ketamine Clinic Beside a Washington Outpatient Program
Drawn from Washington’s pharmacy and facility licensing statutes, the state’s corporate practice case law and federal controlled substance and confidentiality rules. Washington has no licensing category written for ketamine clinics, so read this as a working interpretation to check with counsel and DOH.
An outpatient BHA certification covers counseling and the other behavioral health services listed on it, not a medical infusion. A Washington outpatient SUD provider who wants to offer ketamine is usually standing up a second, medical business, and state law doesn’t stand in the way. For a patient who began ketamine during a residential stay, that clinic is also the natural place to finish the series.
What the Clinic Needs and Doesn’t Need
Washington’s pharmacy statute excludes an individual practitioner’s office and a multipractitioner clinic from the Health Care Entity license, so a practitioner-owned ketamine clinic generally buys and stores its drug under the prescriber’s own DEA registration at the clinic address, with no pharmacy license from the state. The ambulatory surgical facility license under chapter 70.230 RCW is built around surgical procedures, and our reading is that a sub-anesthetic infusion isn’t surgery, though a call to DOH before signing a lease settles it for a specific site. One Washington advantage stands out. ARNPs have full practice authority and can own a PLLC outright, so a psychiatric ARNP can anchor the clinic without a physician partner. The ownership structure, the MSO agreement and the fate of Third Substitute Senate Bill 5387 are covered in the ketamine section of Washington Drug and Alcohol Inpatient Treatment Licensing, along with the open question about RN-run psychiatric infusions under the nursing board’s sedation opinion.
Keeping the Two Businesses Apart
Sharing a building is fine. Sharing records, staff and inventory without paperwork is where trouble starts. The BHA application and the accreditor’s files should show which rooms and staff hours belong to the outpatient program, and the shared-space answer in the FAQ below applies here as much as anywhere. Ketamine stays locked in the clinic’s own storage under the clinic’s registration, out of reach of counseling staff. Most outpatient SUD programs fall under 42 CFR Part 2, so a client’s addiction treatment records cross to the clinic only with that client’s written consent, even when the two businesses share an owner and a receptionist. Referrals between them also fall under the federal Eliminating Kickbacks in Recovery Act, which makes it worth having healthcare counsel look at any payment flowing between the program and the clinic.
Writing the Protocol Without a State Standard
With no Washington ketamine rule and the medical commission still studying the topic, the clinic’s written protocol carries more weight than it would in a state that has put a ketamine standard in writing. Build it from a published standard, such as the 2017 American Psychiatric Association consensus statement or the 2026 ASKP3 consensus guidelines on IV ketamine for depression, and cover screening, dosing ceilings, vital-sign monitoring, discharge criteria and adverse event handling. If the commission or the nursing board later issues guidance, a clinic that already works from a recognized standard will have less to change. Patients can’t drive themselves home after either IV ketamine or Spravato, so the protocol should also make a confirmed ride a condition of booking. A clinic offering Spravato also needs REMS certification and at least two hours of post-dose monitoring with pulse oximetry.
Staffing an Outpatient Program
A typical outpatient program needs a clinical director and counseling staff credentialed as Substance Use Disorder Professionals (SUDP). Many outpatient programs run efficiently with SUDP Trainees building their 2,500 supervised hours under a fully credentialed SUDP director’s direct oversight, rather than staffing every counseling role at the fully independent level.
A small outpatient program with a clinical director and two to three counselors commonly runs $200,000 to $280,000 a year in clinical payroll, with Washington’s addiction and behavioral health counselors earning a median of $68,910 statewide, notably above the national median of $59,350. Most Washington outpatient programs never pay that number in full, and structured supervision is why. Bringing on SUDPT staff who are actively building supervised hours toward full SUDP certification, under a qualified director’s oversight, keeps clinical payroll down while giving your team a genuine growth path. That specific staffing plan follows once the service mix is finalized.
How to Submit Your BHA Application
DOH’s Behavioral Health Agency License Application Packet covers outpatient certifications as a selectable section on the same BHA application (an online version is also available). Send the application and your fee payment to the Department of Health, P.O. Box 1099, Olympia, WA 98507-1099, and any follow-up documents to Behavioral Health Agency Licensing, P.O. Box 47877, Olympia, WA 98504-7877. DOH answers questions at (360) 236-4700.
What Slows Down an Outpatient Application
The most common issue isn’t DOH’s own review speed. It’s a certification scope that doesn’t match the outpatient services the program will actually deliver, which forces a revised application after the on-site review has already started. The second common issue is starting accreditation too late to align with DOH’s initial review, missing the chance to pursue deemed status from the outset.
Frequently Asked Questions
How long does outpatient SUD licensing take in Washington?
A realistic range is 6 to 12 months from initial application to a licensed, operating program, with the timeline driven mostly by site readiness and staffing rather than DOH’s own processing pace.
Do all outpatient SUD programs in Washington need national accreditation?
No. Accreditation is optional, but agencies that pursue it can be deemed to meet state standards and have their ongoing DOH inspections replaced by the accreditor’s review under WAC 246-341-0310.
Can an outpatient SUD program share space with another type of provider in Washington?
It is possible, but the space still needs to meet DOH’s expectations for confidentiality and appropriate clinical space, and any shared arrangement should be clearly documented in the application.
Building an outpatient SUD program in Washington? Reach out here.
Sources
- Washington Administrative Code, WAC 246-341-0300: Agency licensure and certification, general information (checked October 8, 2026)
- Washington Administrative Code, WAC 246-341-0737: Behavioral health outpatient intervention, assessment and treatment services (checked October 8, 2026)
- Washington Administrative Code, WAC 246-341-0310: Agency licensure and certification, deeming (checked October 8, 2026)
- Washington Administrative Code, WAC 246-341-0320: Agency licensure and certification, on-site reviews (checked October 8, 2026)
- Washington State Department of Health: Behavioral Health Agencies, inspection process (checked October 8, 2026)
- Washington State Department of Health, DOH 611-020 (June 2026): Behavioral Health Agency License Application Packet (checked October 8, 2026)
- Revised Code of Washington, RCW 18.64.011: Pharmacy definitions, including health care entity (checked October 8, 2026)
- Washington Administrative Code, chapter 246-811 WAC: Substance use disorder professionals and trainees (checked October 8, 2026)
- Drug Enforcement Administration: Letter on elimination of the DATA-Waiver (checked October 8, 2026)
- Washington State Board of Nursing: ARNP license and prescriptive authority (checked October 8, 2026)
- Washington State Board of Nursing, NCAO 7.1: Administration of Sedating, Analgesic, and Anesthetic Agents (checked October 8, 2026)
- U.S. Food and Drug Administration: Spravato prescribing information (checked October 8, 2026)
- Washington Legislature, SB 5387 (2025-26): Bill summary and history (checked October 8, 2026)
- U.S. Code, 18 U.S.C. 220: Illegal remunerations for referrals (checked October 8, 2026)
- Code of Federal Regulations, 42 CFR 2.31: Consent requirements (checked October 8, 2026)



